MYBPC3 and hypertrophic cardiomyopathy: Mybpc3 mutations are associated with familial hypertrophic cardiomyopathy in humans (Carrier et al., 1997; Carrier et al., 2015), fibrosis in pigs (Zou et al., 2022), and hypertrophy in mice (Schlossarek et al., 2012; Judge et al., 2015).